55 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
, sepsis, osteoarthritis and others.
AllocetraTM is based on the discoveries of Professor Dror Mevorach, an expert on immune activity, macrophage
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
tumors, sepsis and others.
AllocetraTM is based on the discoveries of Professor Dror Mevorach, an expert on immune activity, macrophage activation
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
conditions.
Brian Schwartz, M.D., has served as a director since December 2020. Dr. Schwartz has wide-ranging experience as a drug development expert
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
and others.
AllocetraTM is based on the discoveries of Professor Dror Mevorach, an expert on immune activity, macrophage activation and clearance of dying
6-K
EX-99.1
kokuyyx1qxn1
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
larlj
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
EX-99.1
xby6kyobb c71eri
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-5.1
090eg7fkaj257 2jan
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
paw007ye
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
96c wu6s6uj
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
dn857ati16we
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
rq8slum82utzeho8iqi
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
0q87y5nhcd upbdw
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
84aj xfvayl
23 May 22
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
8:03am
F-3
EX-5.1
t8evqqtf1ysy03uiwk9
29 Apr 22
Shelf registration (foreign)
8:14am
F-3
zkhl7pzm16w7de
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
vlt cw1ii7o69ry6gs
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm